AMD

Constructive setup with near-breakout momentum and upcoming positive catalyst, but thesis_pct at 68 falls short of the 60+ AND win_prob 65+ convergence bar on the win_prob side barely — and MRVL learning warns against buying at 52-week highs with low risk_quality. Skip on convergence discipline; would reconsider on pullback or post-catalyst confirmation.

Bull thesis is real but thesis_pct (68) sits just above the 60 bar while all other cross-currents — extreme valuation, low intrinsic risk quality, and price extended near 52-week high — echo the MRVL loss pattern. Fails the convergence bar for new_buy on quality. Constructive lean but not enough to initiate.

Momentum and catalyst are strong but thesis (68) and win-probability (60) don't clear the 60/65 convergence bar for a new buy. Extreme valuation and poor risk quality echo the CRWD-type setup — chasing a high-PE AI name near highs without conviction convergence. Constructive lean, not a buy.

Fails the new_buy convergence bar (win_prob 60 < 65). Momentum is fine but valuation is stretched and risk_quality is weak. Nothing here says we need to add AI-chip exposure at these levels when we already own NVDA/AVGO/MRVL/TSM within the fund. Watchlist skip.

Strong momentum and today's direct AI data-center catalyst are supportive, but win_probability at 60 fails the 65 convergence bar for a new buy. At 172x PE with intrinsic risk_quality of 25, the CRWD-style trap (great narrative, no valuation discipline) is exactly what we should avoid. Skip on convergence rule.

Strong momentum but win_probability=60 and thesis_pct=68 both miss the new_buy convergence bar. Extended multiple with recent -4% pullback reads like late-cycle chase, not durable setup. Skip.

Win-probability at 60 fails the 65 convergence bar for new_buy. Positive catalyst and decent momentum, but 172x PE and low intrinsic risk quality echo the CRWD pattern — narrative without valuation discipline. Constructive stock, but not a fresh entry here.

AMD has the best momentum in the batch and rides the 'NVDA alternative' narrative, but at 172x PE with only a 60 win-probability the risk/reward is asymmetric the wrong way. Fails the new_buy convergence test (needs both thesis>=60 AND win_prob>=65). Skip on forward view.

Constructive setup with strong momentum and improving competitive position, but win_probability of 60 falls below the 65 threshold required for a new_buy. 172x PE and low risk_quality mean the margin for error is thin. Watchlist status appropriate; would need either a valuation reset or clearer win-probability signal to initiate.

Bull setup is decent but does not clear the 60/65 convergence bar (win_prob 60). Extreme PE plus low intrinsic risk quality make this a wait-and-see. Skip on watchlist.

Best momentum in the batch and a directly relevant agentic-AI catalyst, but win-probability of 60 fails the 65 convergence bar and risk quality is poor. Constructive story but doesn't clear the new-buy threshold.

Near 52w high with decent momentum and thesis, but win_probability of 60 fails the 65 convergence bar for new_buy. PE 172 and risk_quality of 25 are exactly the warning signs we ignored on AVGO/IREN. Skip — no forced entry without convergence.

Momentum is screaming and the breakout-at-highs pattern matches our winning setup, but win_probability of 60 is below the 65 convergence bar for new buys and thesis at 70 is just at the threshold. Per our learnings, breakouts at extreme PE without strong intrinsic quality are exactly the Broadcom/IREN trap. Constructive but not a convergence buy.

Momentum and proximity to highs are attractive and fit the winning breakout pattern, but win_probability of 60 sits just below the 65 convergence bar for a new buy and risk_quality is poor at 25. Without a named hyperscaler/Nvidia partnership headline specific to AMD, this isn't the setup that's worked. Skip.

Bull thesis with real momentum and a concrete analyst catalyst (Morgan Stanley EPYC Venice unit projections). However win-probability of 58 falls below the 65 convergence bar for new buys, and the specialist explicitly flags the proximity to 52w high as a ceiling on near-term upside. Doesn't quite clear the convergence test. Constructive but not actionable today.

Best price action of the group but win-probability fails the 65 convergence floor for a new buy, and no AMD-specific catalyst is firing. Valuation is extreme and the setup looks like late-cycle chase. Watchlist-only.

Watchlist name fails the new-buy convergence bar (win_prob 58 < 65). Thesis is decent and momentum is the best of the AI chip set in this batch, but proximity to 52w high with stretched valuation caps near-term upside. Not a clear pass on the stock itself, just not a buy here.

Constructive momentum but win_probability=58 fails the 65 convergence bar for new buys, and the 178x PE with proximity to 52w high creates meaningful ceiling risk. Forward expected return is positive but not strong enough to justify initiating against the convergence rule.

Decent momentum and bull narrative but win_probability of 58 fails the 65 convergence bar for new buys. Valuation extreme at 178x PE with stock already near 52wk high limits forward asymmetry. Catalyst is sector-derived not name-specific. Skip — not a convergence setup.

Decent momentum and bull-aligned catalyst but win-probability fails the 65 new-buy bar, and at 178x PE near 52w high the technical ceiling is real. Doesn't meet convergence — skip.

Momentum and catalyst are real, but win-probability of 58 misses the 65 convergence bar for new buys. Valuation is extreme and the stock is already near 52w high with limited room before resistance. Not a clean enough setup to override the rule.

Convergence bar met (thesis 70, win-prob 70) but barely, and the stock is already near resistance with stretched valuation. Bullish setup but not enough edge for a fresh entry given the chip exposure already in the book. Watchlist for breakout confirmation.

Convergence bar requires thesis>=60 AND win_prob>=65 — AMD just clears both at 70/70. But thesis isn't dominant, catalyst is analyst-piece rather than named hyperscaler design win, and stock approaching resistance limits asymmetric upside. Not a clear new_buy when we already own NVDA, AVGO, MRVL in the same lane.

Convergence threshold met (thesis 70, win-prob 70) with a concrete, name-specific catalyst that mirrors the MRVL/MU winner pattern. Per recent learnings, cap the valuation-based risk penalty when a breakout has a real partnership headline behind it. Stock-level call is buy; concentration is Sizer's call.

Decent forward setup but no name-specific catalyst, and competitive signal in Vultr win going to NVDA is a mild negative. Thesis and win-prob both below the 60/65 convergence bar for new_buy. Skip on watchlist.

Decent thesis and momentum but no concrete AMD-specific catalyst — riding generic AI tide near resistance, exactly the pattern our learnings flag for de-rating. Convergence bar for new_buy (thesis>=60 AND win_prob>=65) is just met but quality is weak and catalyst is generic. Pass.

Meets convergence bar (thesis 70, win-prob 70) with concrete named-hyperscaler catalyst (Meta AI chip pact) and Helios rack platform directly attacking Nvidia in AI data centers. Momentum at 96 with near-breakout setup is the pattern that worked on MRVL/MU. Per ARM learning, cap the valuation-based risk penalty when catalyst + momentum + range-position all converge. Sector concentration is Sizer's problem.

Matches the winning pattern: AI-infra hardware with named hyperscaler catalyst (Citi/Meta GPU deal) and strong momentum. Thesis 70 is below the 60 floor but win_probability 70 just meets the bar — convergence is borderline (thesis_pct 70 OK, win_prob 70 over 65). The MRVL learning says cap valuation penalty when catalyst+momentum+breakout align. However thesis_pct of 70 vs other names in batch suggests skip rather than new_buy; conviction reflects the genuine forward setup.

Convergence bar not met — thesis 70 and win-prob 52 both fall short for new_buy. Meta pact is real but valuation leaves no margin and the recent -10.86% week signals exhaustion. Pass.

Meta partnership is real but win probability and risk quality are weak, and thesis at 70 doesn't clear the 60+/65+ convergence bar. Sharp 5d drawdown signals momentum has rolled over. Skip.

Watchlist name fails new-buy convergence rule (thesis 70 ok but win_prob only 52). Sharp 5d breakdown and stretched valuation argue against chasing. Skip.

Fails new-buy convergence bar (need thesis>=60 AND win_prob>=65; win_prob only 52). Extreme valuation and sharp 5d breakdown argue against initiating, especially given existing chip concentration. Skip.

Watchlist name fails the new_buy convergence bar — thesis 70 is at the line but win_prob 52 is well below 65 threshold. Extreme PE, sharp 5d breakdown, and high correlation with existing chip holdings make this a clear skip. No urgency from catalyst justifies action.

Watchlist name failing the convergence requirement — win_probability=52 well below the 65 floor for new buys. Sharp 11% 5d decline, extreme valuation, and weak intrinsic risk score. No reason to chase here.

Watchlist name fails the new_buy convergence test — win_prob 52 is well below the 65 threshold. Thesis is fine but AMD continues to lose AI share to NVDA, and the valuation leaves no room for error. Sector also already concentrated. Skip until momentum stabilizes.

Fails new-buy convergence (win_prob 52 < 65). Sharp 5-day breakdown, extreme valuation, and would worsen sector concentration. No reason to act.

Classic AMD setup from our learnings: thesis_pct=70, catalyst_pct=80, near 52wk high, with a landmark Barclays upgrade directly citing agentic AI. Win-prob at 58 is below the standard 65 floor, but the AMD-specific override applies (thesis+catalyst+momentum+range alignment). Don't let valuation caution veto entry again. Concentration is the sizer's job.

AMD is interesting but fails the convergence bar (win_prob 58 < 65) and momentum_pct=46 doesn't meet the AMD-style breakout override criteria (need momentum_pct >= 75). Constructive watchlist name but no new buy here. Concentration concerns also real.

Per AMD learning, when thesis>=70 AND catalyst>=70 AND momentum>=75 AND range>=95 we override the win-prob floor. Here catalyst is 60 and momentum only 48 — the breakout override conditions are not met. Win-prob 58 falls short of the 65 bar. Constructive watchlist name but doesn't clear convergence today.

Watchlist name with momentum/catalyst breakout profile that matches the AMD-miss learning. However, win_prob=58 and thesis_pct=70 don't clear the convergence bar (60/65). The learning notes accept lower win_prob only when momentum >=75 AND range_position >=95 AND thesis+catalyst >=70 — AMD is borderline but 5d is stalling (-0.38%). Skip for now; revisit on confirmed breakout above $527.

This is the AMD pattern the learnings explicitly call out — thesis>=70, catalyst>=65, momentum>=75, near 52wk high. Prior cycle we let win_probability veto and missed +43%. Applying the documented override: accept win_prob of 58 given the convergence of thesis/catalyst/momentum at a breakout. Risk_quality 25 and sector concentration are real but belong to Portfolio Sizer. New buy with constructive conviction.

Per AMD-learning override, when thesis+catalyst+momentum align at 95%+ range we could relax the win-prob floor — but here momentum_pct is only 70 and the stock is showing -0.38% 5d stall at resistance, not a clean breakout. Without breakout confirmation, the convergence bar isn't quite met. Watch for breakout above $527 as trigger.

Unlike the prior AMD lesson, this read has catalyst going AGAINST AMD (NVDA Arm PC chip explicitly targets AMD's CPU business) and momentum stalling at 52w high. The override conditions don't apply when the catalyst is negative. Skip.

Convergence test fails: thesis 74 clears bar but win_probability 68 just above the 65 floor with risk_quality of 25 and PE 156 near all-time highs. Not a 'great company, great price' setup. Hold off; not adding to chip concentration without stronger conviction.

AMD meets the convergence bar narrowly: thesis_pct=74 and win_probability=68 both above thresholds, with momentum/performance at the top of the batch and a clean breakout pattern that matches our MU/MRVL winning fingerprint. Risk_quality is low on valuation but intrinsic-only; sizer handles concentration. Starter new_buy warranted.

AMD has the momentum and catalyst fingerprint we want (breakout, direct headlines, server TAM raise), and win_prob=68 + thesis=74 nearly clears convergence bar but thesis just misses 60+. However, sizer-level concentration concern is meaningful here given five existing chip holdings. Hold conviction constructively but defer new buy to portfolio sizer.

Strong momentum and direct competitive catalyst, but convergence bar not cleanly met: thesis_pct 74 and win_prob 68 are both below the 'great company, great price' standard for new buys. Risk_quality 25 is weak. Stock has already run 330% off lows — chasing here near ATH without a clean thematic-news cluster headline specific to AMD is exactly the late-cycle entry we want to avoid. Skip.

AMD meets the convergence bar marginally (thesis 74, win-prob 68) with strong momentum and direct AI agentic catalyst headlines today. Per learnings, peer in active AI-silicon news cluster with held winners (MRVL, NVDA) deserves a second look despite high PE. Starter position warranted; Portfolio Sizer can manage sector concentration.

Watchlist name with explosive momentum and direct catalyst (Jensen comments). However convergence bar fails: thesis_pct=74 and win_prob=68 are both just shy of the 60/65 floor when accounting for stretched valuation (PE 156) and high correlation to existing NVDA/TSM/MRVL/AVGO book. Promising but not enough edge to add another correlated chip name today.

AMD meets the convergence bar narrowly (thesis 74, win_prob 68) and shows the breakout fingerprint we want — near 52w high, strong momentum, direct ticker mention in 'best AI chips to buy' headlines alongside NVDA/AVGO. Risk quality is poor but that's an intrinsic-vol issue the sizer can handle. Starter position warranted; let sizer decide weight given concentration.

AMD pattern matches the prior miss — strong thesis (74), exceptional momentum (98) and performance (84), direct catalysts. However, win_probability sits at 52, below the 65 floor for new_buy convergence. Recent learnings suggest flooring win_prob at 60 when thesis+performance+range align, but we're still below 65 even with that adjustment. Score this constructively (70) to keep it tracked, but do not initiate today. If win_prob ticks up next read, flip to new_buy.

AMD shows the breakout/momentum pattern our learnings flagged, but win_probability=52 is below the 65 convergence bar for new buys. Per AMD-specific learning, we floor win_prob at 60 when thesis>=70, performance>=90, range>=99 — but even floored, it doesn't clear 65. Catalyst also lacks a direct named-partnership headline. Keep on watchlist; do not whipsaw.

AMD has the breakout profile (perf 97, momentum 98, near 52wk highs) but win-probability at 52 fails the >=65 convergence bar for new_buy. The recent learnings flag AMD as a name where valuation vetoes hurt us — applying the floor-at-60 rule lifts conviction, but momentum is actively deteriorating (-5.69% 5d) which weakens the breakout pattern. Hold off new buy until win-prob crosses 60+ or momentum re-accelerates.

AMD remains the AMD problem from learnings. Strong thesis/momentum/performance but win-probability stuck at 52 — below the 65 bar for new_buy. Per learnings I'd floor win_prob at 60 here, but even adjusted it doesn't clear convergence. Recent -5.69% 5d also breaks the breakout pattern. Skip but keep watching; if win_prob lifts to 65+ with momentum restored, flip.

AMD pattern matches our prior miss — strong performance/momentum but win-prob (52) below the 65 convergence bar. Per learning notes, we should not whipsaw, but new_buy requires BOTH thesis>=60 AND win_prob>=65; win_prob fails. Recent -5.69% 5d weakness and sector concentration argue for patience. Skip, but elevated relative to other passes given strong technical profile.

Per the AMD learning, when thesis_pct>=70 and performance_pct>=90 and range near 52w high we should floor win_probability. AMD is at 74/100/range-near-high but win_prob 52 is still under the 65 new_buy bar. Recent momentum loss (-5.69%) and 141x PE keep this from clearing convergence. Keep on watchlist with elevated conviction but do not initiate today.

AMD has the technical/performance profile we historically underweighted to our regret, but win_probability at 52 fails the >=65 convergence bar for new buys. Recent -5.7% 5d weakness and stretched valuation argue for patience. Keep on watch — if score crosses 88 on a momentum re-acceleration we flip to new_buy per the AMD learning rule.

Strong breakout-confirmed setup with direct catalysts — exactly the pattern our AMD learning flagged. However, convergence rule still requires win_prob >= 65 for new_buy and AMD sits at 52. Per the learning we loosened to >=45, which would qualify, but the sector is already over-concentrated and we hold NVDA/AVGO/MRVL/TSM covering this thesis. Skip on portfolio fit, not stock quality.

AMD matches the recent-learnings pattern exactly: thesis_pct >= 70, performance_pct 100, breakout-confirmed. Per the loosened veto rule (cap win-prob requirement at 45 when breakout+thesis align), this clears for new_buy despite win_prob 52. This is the AMD-miss lesson — don't sit out a confirmed breakout. Modest sizing given concentration concerns, but worth a starter position.

AMD triggers the explicit AMD-pattern loosened veto from recent learnings: thesis_pct=74, performance_pct=100, near 52wk high, momentum>=57. Per the playbook, win_prob veto is capped here. Convergence isn't textbook but the +105% miss is the lesson — take a starter. Sizer can manage chip-sector concentration.